ZNF383

gene
On this page

Also known as FLJ35863Zfp383

Summary

ZNF383 (zinc finger protein 383, HGNC:18609) is a protein-coding gene on chromosome 19q13.13, encoding Zinc finger protein 383 (Q8NA42). May function as a transcriptional repressor, suppressing transcriptional activities mediated by MAPK signaling pathways.

The protein encoded by this gene is a KRAB-related zinc finger protein that inhibits the transcription of some MAPK signaling pathway genes. The repressor activity resides in the KRAB domain of the encoded protein.

Source: NCBI Gene 163087 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 60 total
  • MANE Select transcript: NM_001387601

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18609
Approved symbolZNF383
Namezinc finger protein 383
Location19q13.13
Locus typegene with protein product
StatusApproved
AliasesFLJ35863, Zfp383
Ensembl geneENSG00000188283
Ensembl biotypeprotein_coding
OMIM619499
Entrez163087

Gene structure

Transcript identifiers

Ensembl transcripts: 20 — 16 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000352998, ENST00000585441, ENST00000586068, ENST00000586658, ENST00000588250, ENST00000588371, ENST00000589413, ENST00000590503, ENST00000684119, ENST00000882182, ENST00000882183, ENST00000938216, ENST00000938217, ENST00000938218, ENST00000938219, ENST00000938220, ENST00000938221, ENST00000952120, ENST00000952121, ENST00000952122

RefSeq mRNA: 14 — MANE Select: NM_001387601 NM_001345947, NM_001345948, NM_001345949, NM_001387593, NM_001387594, NM_001387595, NM_001387596, NM_001387597, NM_001387598, NM_001387599, NM_001387600, NM_001387601, NM_001387602, NM_152604

CCDS: CCDS12501

Canonical transcript exons

ENST00000684119 — 6 exons

ExonStartEnd
ENSE000024356463723554937235675
ENSE000028203343722481837224939
ENSE000035003393723040937230462
ENSE000036901653723597937236074
ENSE000039174443721821437218274
ENSE000039178873724246937248740

Expression profiles

Bgee: expression breadth ubiquitous, 188 present calls, max score 82.05.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.7395 / max 71.7681, expressed in 1453 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1755423.18581335
1755410.5536320

Top tissues by expression

242 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
granulocyteCL:000009482.05gold quality
calcaneal tendonUBERON:000370181.76gold quality
colonic epitheliumUBERON:000039781.74gold quality
hindlimb stylopod muscleUBERON:000425280.08gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099180.00gold quality
bone marrow cellCL:000209279.29gold quality
muscle of legUBERON:000138378.68gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.63gold quality
gastrocnemiusUBERON:000138878.49gold quality
smooth muscle tissueUBERON:000113577.38gold quality
cortical plateUBERON:000534377.19gold quality
ganglionic eminenceUBERON:000402376.84gold quality
leukocyteCL:000073876.56gold quality
stromal cell of endometriumCL:000225576.26gold quality
ventricular zoneUBERON:000305376.15gold quality
monocyteCL:000057676.03gold quality
mucosa of stomachUBERON:000119975.94gold quality
olfactory segment of nasal mucosaUBERON:000538675.69gold quality
islet of LangerhansUBERON:000000675.63gold quality
rectumUBERON:000105275.33gold quality
popliteal arteryUBERON:000225075.03gold quality
tibial arteryUBERON:000761075.03gold quality
skin of legUBERON:000151174.69gold quality
adrenal tissueUBERON:001830374.69gold quality
left ovaryUBERON:000211974.61gold quality
skin of abdomenUBERON:000141674.41gold quality
muscle layer of sigmoid colonUBERON:003580574.30gold quality
descending thoracic aortaUBERON:000234574.11gold quality
aortaUBERON:000094774.08gold quality
endocervixUBERON:000045874.00gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-7303no23.15
E-ANND-3no5.92

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

1 targets.

TargetRegulation
JUNRepression

JASPAR motifs

MotifNameFamily
MA1979.1ZNF416More than 3 adjacent zinc fingers
MA1979.2ZNF416More than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:25690854

Literature-anchored findings (GeneRIF, showing 2)

  • Overexpression of ZNF383 in cells inhibits the transcriptional activities of AP-1 and SRE, suggesting that ZNF383 may act as a negative regulator in MAPK-mediated signaling pathways. (PMID:15964543)
  • 19q13.12 KRAB zinc-finger protein ZNF383 represses p53 signaling pathway by interacting with p53. (PMID:35835334)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusZfp383ENSMUSG00000099689
rattus_norvegicusZfp420ENSRNOG00000020774

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)

Protein

Protein identifiers

Zinc finger protein 383Q8NA42 (reviewed: Q8NA42)

All UniProt accessions (3): Q8NA42, K7EJN0, K7ELW4

UniProt curated annotations — full annotation on UniProt →

Function. May function as a transcriptional repressor, suppressing transcriptional activities mediated by MAPK signaling pathways.

Subcellular location. Nucleus. Cytoplasm.

Tissue specificity. Expressed in heart, placenta, liver, pancreas and with a higher level in skeletal muscle.

Domain organisation. The KRAB domain is responsible for the transcriptional repressor activity.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (14): NP_001332876, NP_001332877, NP_001332878, NP_001374522, NP_001374523, NP_001374524, NP_001374525, NP_001374526, NP_001374527, NP_001374528, NP_001374529, NP_001374530, NP_001374531, NP_689817 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050826Krueppel_C2H2_ZnFingerFamily

Pfam: PF00096, PF01352, PF13465

UniProt features (16 total): zinc finger region 11, sequence conflict 3, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NA42-F173.360.30

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 62 (showing top): IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, GOCC_NUCLEAR_ENVELOPE, GOCC_NUCLEAR_MEMBRANE, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOCC_ORGANELLE_ENVELOPE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, IRF5_TARGET_GENES, NCOA2_TARGET_GENES, NFE2L1_TARGET_GENES, RYBP_TARGET_GENES, ZBTB12_TARGET_GENES, ZBTB18_TARGET_GENES, ZNF33A_TARGET_GENES, ZNF391_TARGET_GENES, ZNF618_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (4): nucleoplasm (GO:0005654), cytoplasm (GO:0005737), nuclear membrane (GO:0031965), nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
cellular anatomical structure2
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
cis-regulatory region sequence-specific DNA binding1
transcription cis-regulatory region binding1
transcription regulator activity1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
nuclear lumen1
intracellular anatomical structure1
nucleus1
nuclear envelope1
organelle membrane1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

882 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF383CEP170Q5SW79446
ZNF383USP6P35125418
ZNF383TMBIM6P55061391
ZNF383YPEL3P61236387
ZNF383ACOT13Q9NPJ3383
ZNF383PCMT1P22061379
ZNF383UGGT2Q9NYU1377
ZNF383PARS2Q7L3T8371
ZNF383EMG1Q92979371
ZNF383TDP2O95551366
ZNF383BAG4O95429364
ZNF383RPL6Q02878363
ZNF383ZNF326Q5BKZ1362
ZNF383HSPA8P11142354
ZNF383NEK7Q8TDX7353
ZNF383PHB2Q99623353

IntAct

21 interactions, top by confidence:

ABTypeScore
ZNF572ZNF383psi-mi:“MI:0915”(physical association)0.560
TLE5ZNF383psi-mi:“MI:0915”(physical association)0.560
ZNF383ZIM2psi-mi:“MI:0915”(physical association)0.560
ZNF383RCOR3psi-mi:“MI:0915”(physical association)0.560
NOL4ZNF383psi-mi:“MI:0915”(physical association)0.560
TRIM28ZNF320psi-mi:“MI:0914”(association)0.530
EWSR1ZNF383psi-mi:“MI:0915”(physical association)0.370
ZNF383ZNF195psi-mi:“MI:0914”(association)0.350
SLC7A9CDC7psi-mi:“MI:0914”(association)0.350
NRASIGKV2D-24psi-mi:“MI:0914”(association)0.350
ZNF572ZNF383psi-mi:“MI:0915”(physical association)0.000
TLE5ZNF383psi-mi:“MI:0915”(physical association)0.000
ZIM2ZNF383psi-mi:“MI:0915”(physical association)0.000
RCOR3ZNF383psi-mi:“MI:0915”(physical association)0.000
NOL4ZNF383psi-mi:“MI:0915”(physical association)0.000

BioGRID (21): ZNF383 (Affinity Capture-RNA), ZNF383 (Two-hybrid), ZNF383 (Two-hybrid), ZNF383 (Two-hybrid), ZNF383 (Two-hybrid), ZIM2 (Two-hybrid), LRP4 (Affinity Capture-MS), ZNF195 (Affinity Capture-MS), ZNF644 (Affinity Capture-MS), LRP5 (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), IKBIP (Affinity Capture-MS), LRP6 (Affinity Capture-MS), TRIM24 (Affinity Capture-MS), UBR1 (Affinity Capture-MS)

ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21

Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

60 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance56
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1046 predictions. Top by Δscore:

VariantEffectΔscore
19:37227991:G:GTdonor_gain1.0000
19:37230461:AGG:Adonor_loss1.0000
19:37230463:G:GCdonor_loss1.0000
19:37230464:T:Adonor_loss1.0000
19:37232725:A:Tdonor_gain1.0000
19:37235545:TCA:Tacceptor_loss1.0000
19:37235546:CAG:Cacceptor_loss1.0000
19:37235547:A:AGacceptor_gain1.0000
19:37235547:A:Gacceptor_loss1.0000
19:37235547:AG:Aacceptor_gain1.0000
19:37235547:AGG:Aacceptor_gain1.0000
19:37235548:G:GCacceptor_gain1.0000
19:37235548:GG:Gacceptor_gain1.0000
19:37235548:GGG:Gacceptor_gain1.0000
19:37235672:ATGGG:Adonor_loss1.0000
19:37235673:TGGGT:Tdonor_loss1.0000
19:37235674:GG:Gdonor_gain1.0000
19:37235675:GG:Gdonor_gain1.0000
19:37235675:GGTAA:Gdonor_loss1.0000
19:37235676:G:GGdonor_gain1.0000
19:37235676:G:GTdonor_loss1.0000
19:37235677:TAAG:Tdonor_loss1.0000
19:37218272:CAGG:Cdonor_loss0.9900
19:37218275:G:Cdonor_loss0.9900
19:37218276:T:Adonor_loss0.9900
19:37235541:T:TAacceptor_gain0.9900
19:37235548:GGGAT:Gacceptor_gain0.9900
19:37242467:A:AGacceptor_gain0.9900
19:37242468:G:GGacceptor_gain0.9900
19:37230460:GAG:Gdonor_gain0.9800

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000051839 (19:37220425 T>C,G), RS1000083133 (19:37244820 T>C), RS1000159617 (19:37220967 A>G), RS1000324243 (19:37233215 C>G,T), RS1000351940 (19:37227345 C>T), RS1000423178 (19:37233782 T>C), RS1000511620 (19:37221206 A>G), RS1000578243 (19:37239346 A>G), RS1000640417 (19:37237375 GA>G,GAA), RS1001090729 (19:37244888 TTTCATG>T), RS1001121747 (19:37222588 G>A), RS1001225507 (19:37245578 G>A,T), RS1001468987 (19:37235091 G>A), RS1001530673 (19:37241278 C>T), RS1001544908 (19:37244637 C>T)

Disease associations

OMIM: gene MIM:619499 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST002097_45Coronary artery calcification7.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004723coronary artery calcification

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

33 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Aflatoxin B1increases expression, increases methylation2
aristolochic acid Iincreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
bisphenol Faffects cotreatment, increases expression1
TAK-243increases sumoylation1
trichostatin Aaffects expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
sodium arsenitedecreases expression1
cupric oxideincreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
abrineincreases expression1
jinfukangdecreases expression1
MT19c compoundincreases expression1
Temozolomideincreases expression1
Arsenic Trioxideaffects cotreatment, decreases expression1
Antimycin Aincreases expression1
Benzo(a)pyreneincreases expression1
Camptothecinincreases expression1
Cytarabineincreases expression1
Dexamethasoneaffects cotreatment, increases expression1
Doxorubicindecreases expression1
Ethyl Methanesulfonateincreases expression1
Formaldehydeincreases expression1
Indomethacinaffects cotreatment, increases expression1
Methyl Methanesulfonateincreases expression1
Tretinoinaffects cotreatment, decreases expression1
Valproic Aciddecreases expression1
1-Methyl-3-isobutylxanthineincreases expression, affects cotreatment1
Cyclosporineincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.